GGrantIndex
← Search

Stanford Cancer Institute

$100,000P30FY2024CANIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

Paper 39574895Paper 39534431Paper 39506045Paper 39378093Paper 39257774Paper 39179931Paper 39163262Paper 39132489Paper 39042439Paper 38997156Paper 38996463Paper 38987048Paper 38968138Paper 38838737Paper 38810650Paper 38746193Paper 38563850Paper 38496616Paper 38496500Paper 38408498Paper 38387457Paper 38278150Paper 38273211Paper 38262408Paper 38260330Paper 38200310Paper 38154193Paper 38096469Paper 37963187Paper 37917579Paper 37882771Paper 37812494Paper 37743567Paper 37667254Paper 37662553Paper 37534980Paper 37532139Paper 37527449Paper 37398193Paper 37244414Paper 37196642Paper 37184546Paper 37162847Paper 36999999Paper 36993756Paper 36813894Paper 36747642Paper 36734849Paper 36729432Paper 36729074Paper 36719070Paper 36717409Paper 36711732Paper 36701540Paper 36652552Paper 36640300Paper 36635501Paper 36624348Trial NCT05220254Trial NCT03733210Trial NCT03405142Trial NCT03241940Trial NCT03179449Trial NCT02855086Trial NCT02805075Trial NCT02762266Trial NCT02736578Trial NCT02735356Trial NCT02699723Trial NCT02695628Trial NCT02690948Trial NCT02683824Trial NCT02635074Trial NCT02624518Trial NCT02599194Trial NCT02581787Trial NCT02488070Trial NCT02440308Trial NCT02432118Trial NCT02429804Trial NCT02415608Trial NCT02401347Trial NCT02215928Trial NCT02210858Trial NCT02203565Trial NCT02184533Trial NCT02175745Trial NCT02166983Trial NCT02058550Trial NCT02030405Trial NCT02019069Trial NCT01977677Trial NCT01943188Trial NCT01928030Trial NCT01926990Trial NCT01908166Trial NCT01904643Trial NCT01898403Trial NCT01893892Trial NCT01868503

Abstract

Project Summary/Abstract This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-041. The Stanford Cancer Institute’s (SCI) mission is to leverage the broad and unique strengths of Stanford University in basic science, bioengineering, population science, biostatistics, technology development, clinical research, clinical care, and translation to (1) improve the diagnosis, treatment, and outcomes of cancer patients; (2) understand cancer etiologies among diverse populations; and (3) decrease cancer incidence in the SCI catchment area and beyond. SCI is committed to improving long-term outcomes by ensuring that cancer survivors have access to guideline concordant survivorship care, including timely referrals to supportive services and preventative care. This proposal is designed to evaluate the alignment of survivorship care delivery within clinical care programs at the Comprehensive Cancer Center in Palo Alto and network sites, with the National Standards for Cancer Survivorship Care. In partnership with operational leaders and project managers at Stanford Healthcare, we will use a mixed methods approach to leverage data that exist in the electronic medical record, cancer center registry, institutional policies, and implementation projects; and supplement this by adding surveys and in-depth interviews with key informants and stakeholders. Integrated data analysis will inform a comprehensive report of the effectiveness and reach of Stanford’s Cancer Survivorship Program, alignment with the National Standards for Cancer Survivorship Care, and gaps and barriers to care delivery. Key findings will provide data to support the allocation of resources, customization of workflows and training of staff and healthcare professionals. Activities proposed in this research are highly aligned with the SCI’s commitment to understand and address gaps in survivorship care and will lead to research initiatives designed to test new models of care and interventions to improve physical, emotional, and mental health. Ultimately, this work aims to harmonize best practices across the Stanford network in line with national survivorship care standards, improve the quality of survivorship care, and thus enhance the long-term outcomes and well-being of all cancer survivors.

View original record on NIH RePORTER →